Full-year 2026 GAAP operating expense guidance was raised to $1.7 billion - $1.8 billion, primarily driven by accelerated ...

BeOne Medicines AG ( NASDAQ:ONC ) defied analyst predictions to release its first-quarter results, which were ahead ...

An experimental drug from Revolution Medicines that nearly ​doubled survival time for patients with advanced pancreas cancer ...

Daraxonrasib demonstrated unprecedented survival benefit in Phase 3 RASolute 302 trial in previously treated metastatic pancreatic cancer; ...

Carol Massar and Tim Stenovec bring together the latest news from the world of business and finance and the interesting stories.

The war in the Middle East has “aggravated the situation”, it is “not the sole reason for the shortage”, said Pharmacy ...

The data published in NEJM reflect outcomes in the PDAC cohort from the RMC-6236-001 trial (NCT05379985), an open-label, multicenter Phase 1/2 trial evaluating daraxonrasib monotherapy in patients ...

1. The non-GAAP adjustments are based on best available information at this time related to non-cash items similar to those reported in our actual Non-GAAP results.

The Andean Community trade bloc ordered Colombia and Ecuador to lift all measures restricting trade between the two countries ...

This all started in 2023 when two different judges gave opposing rulings on abortion medications. Now, RFK is getting ...

A KFF Health News analysis finds TrumpRx and other initiatives offer discounts for some cash-paying patients, but many ...

The deadly Andes strain of hantavirus recently spread on a cruise ship whose passengers included two Houstonians. What does ...